doripenem has been researched along with Pyrexia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H; Hashimoto, T; Hashinaga, K; Hayashidani, H; Nureki, SI; Sakamoto, T; Shigemitsu, O; Takenaka, R | 1 |
| Aoki, Y; Fujishima, Y; Hanamura, I; Ishida, Y; Ito, S; Kowata, S; Mine, T; Oyake, T; Sugawara, N; Takemasa-Fujisawa, Y; Tsukushi, Y | 1 |
| Ishihara, T; Miyazaki, M; Notani, N; Tsumura, H; Yoshiiwa, T | 1 |
| Ichikawa, M; Kurokawa, M; Nannya, Y; Narukawa, K; Toya, T | 1 |
1 review(s) available for doripenem and Pyrexia
| Article | Year |
|---|---|
Septic shock due to Yersinia pseudotuberculosis infection in an adult immunocompetent patient: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Blood Culture; Cefmetazole; Ceftriaxone; Doripenem; Fever; Humans; Immunocompetence; Male; Pneumonia, Bacterial; Shock, Septic; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2021 |
2 trial(s) available for doripenem and Pyrexia
| Article | Year |
|---|---|
Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy-Induced Febrile Neutropenia; Doripenem; Female; Fever; Humans; Leukemia; Male; Meropenem; Middle Aged; Myelodysplastic Syndromes; Prospective Studies | 2019 |
A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Female; Fever; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Risk Factors; Thienamycins; Treatment Outcome | 2012 |
1 other study(ies) available for doripenem and Pyrexia
| Article | Year |
|---|---|
Pyogenic vertebral osteomyelitis caused by Yersinia pseudotuberculosis.
Topics: Aged; Blood Culture; Carbapenems; Clindamycin; Discitis; Doripenem; Drug Therapy, Combination; Fever; Follow-Up Studies; Humans; Infusions, Intravenous; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Osteomyelitis; Rare Diseases; Thoracic Vertebrae; Treatment Outcome; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2016 |